Related Experiment Videos
Emotional distress during interferon-alpha-2B and ribavirin treatment of chronic hepatitis C
Robert J Fontana1, Steven M Schwartz, Achamyeleh Gebremariam
1Department of Internal Medicine and the Consortium for Health Outcomes Innovation and Cost-Effectiveness Studies, University of Michigan Medical School, Ann Arbor, MI 48109-0362, USA. rfontana@unich.edu
Abstract:
The aim of the study was to describe the use of the Brief Symptom Inventory in characterizing the type and severity of emotional distress in 26 patients with chronic hepatitis C who were receiving interferon-alpha-2B and ribavirin. The 6-month actuarial incidence of neuropsychiatric toxicity, determined by physician interview, was 58%. Significant differences in mean depression, anxiety, and somatization Brief Symptom Inventory T scores were noted in the 15 patients with clinically apparent neuropsychiatric toxicity compared to the 11 patients without neuropsychiatric toxicity. Because of its brevity and simplicity, the Brief Symptom Inventory may prove to be a useful adjunct to clinician assessment in detecting and monitoring emotional distress during interferon-alpha treatment of chronic hepatitis C.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis II: Pathophysiology
Chronic Pancreatitis II: Collaborative Care
Assessment:
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...